$AEZS Aeterna Zentaris Inc. | Nasdaq





AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in the development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.
https://www.zentaris.com/